EGFR Inhibitors Boost Glioblastoma Chemotherapy Response
A new study suggests a promising approach for glioblastoma treatment. Researchers found that a specific drug class, EGFR inhibitors, made this aggressive brain cancer more vulnerable to chemotherapy.…